RCKT is trading at $3.29 (-5.33%) today following the announcement that S&P Dow Jones Indices will remove Rocket Pharmaceuticals from the S&P Biotechnology Select Industry Index.

  • The index deletion, effective June 22, 2026, has likely triggered immediate passive ETF selling as funds rebalance their holdings.
  • The removal adds downward pressure to a stock that has already seen significant volatility in recent sessions.
  • Broader biotech market sentiment remains soft, though the index exit is the primary catalyst for today's decline.